Wen Xu, Ph.D.
- 3Articles
- 8.8KReads1
- 2006–2009Active
- 14Collaborators
- 93Citations2
About
Wen Xu, Ph.D., has published research focused on the treatment of schizophrenia and schizoaffective disorders, with particular attention to antipsychotic medications such as olanzapine, aripiprazole, and ziprasidone. The work includes clinical trials assessing drug safety, efficacy, and quality of life outcomes in patients, including adolescents. Xu’s contributions span neurology and psychiatric clinical research from 2006 to 2009.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
